Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morganto

Recalled March 15, 2017 · FDA recall D-0493-2017 · Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Hazard

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled · FDA Class II

Units

58 UD100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each)

Sold at

Nationwide

Description

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled

Product

Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20

Manufacturer(s)

Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →